Researchers identified a monocyte/dendritic cell response to EBV reactivation in B cells as one of the earliest events in developing MS relapse.
The post Pre-Relapse Immune Signature Implicates EBV Reactivation in MS Relapse first appeared on Physician’s Weekly.
